Kukjeon Pharmaceutical Co Ltd
KOSDAQ:307750
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Raisecom Technology Co Ltd
SSE:603803
|
CN |
|
Shenzhen Forms Syntron Information Co Ltd
SZSE:300468
|
CN |
|
Solar Industries India Ltd
NSE:SOLARINDS
|
IN |
|
J
|
Jinneng Holding Shanxi Electric Power Co Ltd
SZSE:000767
|
CN |
|
A
|
Amyris Inc
F:3A01
|
US |
|
Macrotech Developers Ltd
NSE:LODHA
|
IN |
|
E
|
East China Engineering Science and Technology Co Ltd
SZSE:002140
|
CN |
|
C
|
Custodian REIT PLC
LSE:CREI
|
UK |
|
L
|
Ligao Foods Co Ltd
SZSE:300973
|
CN |
|
R
|
Ral Yatirim Holding AS
IST:RALYH.E
|
TR |
|
Swedbank AB
STO:SWED A
|
SE |
|
Mobvista Inc
HKEX:1860
|
CN |
Kukjeon Pharmaceutical Co Ltd
Total Receivables
Kukjeon Pharmaceutical Co Ltd
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
Kukjeon Pharmaceutical Co Ltd
KOSDAQ:307750
|
Total Receivables
₩32.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
326%
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Total Receivables
₩714.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
12%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Total Receivables
₩242.2B
|
CAGR 3-Years
53%
|
CAGR 5-Years
81%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Total Receivables
₩341.8B
|
CAGR 3-Years
23%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-8%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Total Receivables
₩55.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
5%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Total Receivables
₩30.3B
|
CAGR 3-Years
58%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
Kukjeon Pharmaceutical Co Ltd
Glance View
Kukjeon Pharmaceutical Co., Ltd. engages in providing financial support services. The company is headquartered in Anyang, Gyeonggi-Do. The company went IPO on 2018-12-19. The firm manufactures and sells raw materials used in specialized medicines such as choline alfoscerates, benfothiamines, spherical sorbents, and napamostat mesylatse. The firm sells its products in domestic and overseas markets such as Japan.
See Also
What is Kukjeon Pharmaceutical Co Ltd's Total Receivables?
Total Receivables
32.3B
KRW
Based on the financial report for Sep 30, 2025, Kukjeon Pharmaceutical Co Ltd's Total Receivables amounts to 32.3B KRW.
What is Kukjeon Pharmaceutical Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
326%
Over the last year, the Total Receivables growth was 8%. The average annual Total Receivables growth rates for Kukjeon Pharmaceutical Co Ltd have been 8% over the past three years , 326% over the past five years .
